COMPLETE REMISSION IN ACUTE MYELOID LEUKAEMIA AFTER TREATMENT WITH RECOMBINANT HUMAN GRANULOCYTE COLONY‐STIMULATING FACTOR AND HIGH DOSE INTRAVENOUS METHYLPREDNISOLONE